Form Of Securities Purchase Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
EntreMed, Inc. – Form of Securities Purchase Agreement (October 19th, 2017)

This Securities Purchase Agreement (this "Agreement") is dated as of October 13, 2017, between CASI Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively the "Purchasers").

Form of Securities Purchase Agreement (October 13th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of October 11, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and UNION CAPITAL, LLC, a New York limited liability company, with its address at 525 Norton Parkway, New Haven, CT 06511 (the "Buyer").

Form of Securities Purchase Agreement (October 11th, 2017)

This Securities Purchase Agreement (this Agreement) is dated as of October 10, 2017, between MannKind Corporation, a Delaware corporation (the Company), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a Purchaser and collectively the Purchasers).

Form of Securities Purchase Agreement (October 6th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of October 02, 2017, by and between PositiveID Corporation, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, #201, Delray Beach FL, 33445, (the "Company"), and GW Holdings Group, LLC, A New York limited liability company with its executive offices located at 137 Montague St., #291, Brooklyn, NY 11201 (the "Buyer).

China Commercial Credit Inc. – Form of Securities Purchase Agreement (September 29th, 2017)

THIS SECURITIES PURCHASE AGREEMENT ("Agreement") is made as of September 27, 2017 by and between China Commercial Credit Inc., a Delaware corporation (the "Company") and each of the Investors whose names are set forth on the Schedule of Investors attached hereto (individually, an "Investor" and collectively, the "Investors").

Form of Securities Purchase Agreement (September 15th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of September 12, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and UNION CAPITAL, LLC, a New York limited liability company, with its address at 525 Norton Parkway, New Haven, CT 06511 (the "Buyer").

Form of Securities Purchase Agreement (September 15th, 2017)

THIS PURCHASE AGREEMENT ("Agreement") is made as of the 11th day of September, 2017 by and between PositiveID Corp.,(the "Company"), and GHS Investments, LLC (the "Investor").

Form of Securities Purchase Agreement (August 25th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of August 21, 2017, by and between POSITIVEID CORPORATION, a Delaware corporation, with its address at 1690 South Congress Avenue, Suite 201, Delray Beach, Florida 33445 (the "Company"), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the "Buyer").

Medgenics Inc – Form of Securities Purchase Agreement (August 11th, 2017)

This Securities Purchase Agreement (this "Agreement") is dated as of [____], 2017 by and among Aevi Genomic Medicine, Inc., a Delaware corporation (the "Company"), and each purchaser listed on Schedule A attached hereto (each, including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").

Sito Mobile, Ltd. – Form of Securities Purchase Agreement (July 24th, 2017)

SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of July 24, 2017 by and between SITO MOBILE, LTD., a Delaware corporation (the "Company"), and the Investor set forth on the signature page affixed hereto (the "Investor"). Capitalized terms used herein and not otherwise defined herein are defined in Section 6 hereof.

Form of Securities Purchase Agreement (July 21st, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of July 17, 2017, by and between POSITIVEID CORPORATION, a Delaware corporation, with its address at 1690 South Congress Avenue, Suite 201, Delray Beach, Florida 33445 (the "Company"), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the "Buyer").

Form of Securities Purchase Agreement (June 9th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of June 6, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and UNION CAPITAL, LLC, a New York limited liability company, with its address at 525 Norton Parkway, New Haven, CT 06511 (the "Buyer").

Form of Securities Purchase Agreement (May 26th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of May 23, 2017, by and between POSITIVEID CORPORATION, a Delaware corporation, with its address at 1690 South Congress Avenue, Suite 201, Delray Beach, Florida 33445 (the "Company"), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the "Buyer").

Form of Securities Purchase Agreement (May 26th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of May 22, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and ESSEX GLOBAL INVESTMENT CORP, a Nevada limited liability company, with its address at 271 Highway 46W Suite H113, Fairfield, NJ 07004 (the "Buyer").

Amyris – Form of Securities Purchase Agreement (May 8th, 2017)

This Securities Purchase Agreement (this "Agreement") is dated as of May __, 2017, between Amyris, Inc., a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively the "Purchasers").

Form of Securities Purchase Agreement (May 5th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of May 2, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and CROSSOVER CAPITAL FUND II, LLC, with its address at 365 Ericksen Ave. NE #315, Bainbridge Island, WA 98110 (the "Buyer").

Arkados Group – Form of Securities Purchase Agreement (May 5th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of May 1, 2017, by and between ARKADOS GROUP, INC., a Delaware corporation, with headquarters located at 211 Warren Street, Suite 320, Newark, NJ 07103 (the "Company"), and __________________________, with its address at __________________(the "Buyer").

South American Properties, Inc. – Form of Securities Purchase Agreement (April 21st, 2017)

This SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of _______ ___, 2016, is entered into by and between The Chron Organization, Inc. (OTCPk: CHRO), a Nevada corporation, ("Chron" or the "Company"), and ________________ (the "Buyer").

Form of Securities Purchase Agreement (April 21st, 2017)

THIS PURCHASE AGREEMENT ("Agreement") is made as of the 17th day of April, 2017 by and between PositiveID Corp.,(the "Company"), and GHS Investments, LLC (the "Investor").

Form of Securities Purchase Agreement (April 21st, 2017)

This Securities Purchase Agreement (this Agreement) is dated as of April 20, 2017, between Social Reality, Inc., a Delaware corporation (the Company), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a Purchaser and collectively, the Purchasers).

Amyris – Form of Securities Purchase Agreement (April 17th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of [_____], 2017, is by and among Amyris, Inc., a Delaware corporation (the "Company"), and [_______] (the "Investor").

Form of Securities Purchase Agreement (March 17th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of March 14, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and UNION CAPITAL, LLC, a New York limited liability company, with its address at 525 Norton Parkway, New Haven, CT 06511 (the "Buyer").

GrowGeneration Corp. – Form of Securities Purchase Agreement (March 16th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of _______, 2017, is by and among GrowGeneration Corp., a Colorado corporation with offices located at 503 North Main Street, Pueblo, Colorado 81003 (the "Company"), and the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").

Stevia First Corp. – Form OF SECURITIES PURCHASE AGREEMENT (March 13th, 2017)

This Securities Purchase Agreement (this "Agreement") is dated as of March 9, 2017, between Vitality Biopharma, Inc., a Nevada corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").

Harvard Apparatus Regenerative Technology, Inc. – Form of Securities Purchase Agreement (February 7th, 2017)

This Securities Purchase Agreement (this "Agreement") is dated as of February ___, 2017, between Biostage, Inc., a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").

Form of Securities Purchase Agreement (February 3rd, 2017)

THIS PURCHASE AGREEMENT ("Agreement") is made as of the 30th day of January, 2017 by and between PositiveID Corp.,(the "Company"), and GHS Investments, LLC (the "Investor").

Form of Securities Purchase Agreement (January 20th, 2017)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of January 13, 2017, by and between PositiveID Corp, a Delaware corporation, with headquarters located at 1690 South Congress Avenue, Suite 201, Delray Beach 33445, (the "Company"), and CROSSOVER CAPITAL FUND II, LLC, with its address at 217 1st Ave S. #4735, Seattle, Washington, 98194 (the "Buyer").

Uni-Pixel – Form of Securities Purchase Agreement (January 18th, 2017)

This SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of January 17, 2017, is by and among Uni-Pixel, Inc., a Delaware corporation with headquarters located at 4699 Old Ironsides Drive, Suite 300, Santa Clara, California 95054 (the "Company"), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").

Amyris – Form of Securities Purchase Agreement (December 2nd, 2016)

This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of [ ], 2016, is by and among Amyris, Inc., a Delaware corporation (the "Company"), and [ ] (the "Investor").

Form of Securities Purchase Agreement (November 21st, 2016)

This Securities Purchase Agreement (this "Agreement") is dated as of ______________, 2016, between Bellerophon Therapeutics, Inc., a Delaware corporation (the "Company"), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a "Purchaser" and collectively, the "Purchasers").

Dryships Inc – Form of Securities Purchase Agreement (November 17th, 2016)

This SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of November 16, 2016, is by and among DryShips Inc., a company incorporated under the laws of the Republic of the Marshall Islands, with headquarters located at 109 Kifisias Avenue and Sina Street, GR 151 24, Amaroussion, Greece (the "Company"), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a "Buyer" and collectively, the "Buyers").

Caladrius Biosciences, Inc. Form of Securities Purchase Agreement (September 15th, 2016)

This Securities Purchase Agreement ("Agreement") is made as of September 14, 2016 (the "Effective Date"), by and among Caladrius Biosciences, Inc., a Delaware corporation (the "Company"), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto (the "Schedule of Purchasers"). Such persons and entities are hereinafter collectively referred to herein as "Purchasers" and each individually as a "Purchaser."

Form of Securities Purchase Agreement (September 15th, 2016)

SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated as of September 14, 2016 by and between CALADRIUS BIOSCIENCES, INC., a Delaware corporation (the "Company"), and ASPIRE CAPITAL FUND, LLC, an Illinois limited liability company (the "Buyer"). Capitalized terms used herein and not otherwise defined herein are defined in Section 7 hereof.

Caladrius Biosciences, Inc. Form of Securities Purchase Agreement (September 15th, 2016)

This Securities Purchase Agreement ("Agreement") is made as of September 14, 2016 (the "Effective Date"), by and among Caladrius Biosciences, Inc., a Delaware corporation (the "Company"), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto (the "Schedule of Purchasers"). Such persons and entities are hereinafter collectively referred to herein as "Purchasers" and each individually as a "Purchaser."

Ampio Pharmaceutical – Form of Securities Purchase Agreement (August 29th, 2016)

This SECURITIES PURCHASE AGREEMENT (this Agreement), dated as of , 2016, is by and among Ampio Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 373 Inverness Parkway, Suite 200, Englewood, Colorado 80112 (the Company), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a Buyer and collectively, the Buyers).